Long-term safety of growth hormone-A combined registry analysis-Reference-Cited by-同舟云学术

Long-term safety of growth hormone-A combined registry analysis

Published:2017-11-20 Issue:4 Volume:88 Page:515-528
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Stochholm Kirstine¹²^ORCID,Kiess Wieland³

Affiliation:

1. Department of Internal Medicine and Diabetes, Endocrinology; Aarhus University Hospital; Aarhus Denmark

2. Department of Pediatrics; Center of Rare Diseases; Aarhus University Hospital; Aarhus Denmark

3. Department of Women and Child Health; Hospital for Children and Adolescents; University Hospitals; University of Leipzig; Leipzig Germany

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13502/fullpdf

Reference96 articles.

1. Pioneering recombinant growth hormone manufacturing: pounds produced per mile of height;Cronin;J Pediatr,1997

2. Current indications for growth hormone therapy for children and adolescents;Richmond;Endocr Dev,2010

3. Indications for recombinant human growth hormone and evaluation of available recombinant human growth hormone devices: implications for managed care organizations;Dunn;Am J Manag Care,2011

4. The diagnosis and treatment of growth hormone deficiency in adults;Clemmons;Curr Opin Endocrinol Diabetes Obes,2010

5. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age;Kappelgaard;Growth Horm IGF Res,2011

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study;Endocrine;2024-01-12

2. Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk;Best Practice & Research Clinical Endocrinology & Metabolism;2023-12

3. Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: Challenging issues, benefits, and risks;Best Practice & Research Clinical Endocrinology & Metabolism;2023-12

4. The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD—a non-inferiority Randomised Controlled Trial (RCT);Trials;2023-08-21

5. The Growth Hormone Deficiency (GHD) Reversal Trial: Effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD – A non-inferiority randomised controlled trial (RCT).;2023-07-24